TCMD on Nasdaq
TACTILE SYSTEMS TECHNOLOGY INC
American surgical and medical instruments and apparatus company.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with ANGIODYNAMICS INC, PROCEPT BioRobotics Corp or SkinHealth Systems Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
75.9%Gross margin3
8.9%Operating margin3
5.8%Net margin3
12.5%Revenue growth, 20253
8.7%Return on equity3
0.00×Debt to equity3
$40.4MFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Lymphedema products brought in 76% of the revenue TACTILE SYSTEMS TECHNOLOGY INC broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Lymphedema products | $241.7M | $259.4M | $278.4M |
| Airway clearance products | $32.7M | $33.6M | $51.1M |
| Rental revenue | $34.9M | $37.0M | $36.9M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue24¢$79.4M
- Research and development3¢$8.5M
- Other costs64¢$210.3M
- Income tax4¢$12.3M
- Profit6¢$19.1M
Out of $329.5M in revenue.3
Where each dollar of operating cash went, fiscal 2025
- Capital spending6¢$2.4M
- Share buybacks62¢$26.6M
- Kept or used elsewhere32¢$13.9M
Out of $42.8M of cash from operations.3
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total revenue | $329.5M | $293.0M | $274.4M |
| Total cost of revenue | $79.4M | $76.3M | $79.3M |
| Gross profit | $250.1M | $216.7M | $195.1M |
| Sales and marketing | $121.2M | $112.0M | $107.1M |
| Research and development | $8.5M | $8.8M | $7.8M |
| Reimbursement, general and administrative | $88.7M | $71.1M | $62.1M |
| Intangible asset amortization and earn-out | $2.4M | $2.5M | $76.0K |
| Total operating expenses | $220.9M | $194.5M | $177.1M |
| Income from operations | $29.3M | $22.2M | $18.0M |
| Interest income | $3.1M | $3.4M | $1.9M |
| Interest expense | -$1.0M | -$2.1M | -$4.1M |
| Other income | $1.0K | $9.0K | $2.0K |
| Income before income taxes | $31.3M | $23.5M | $15.8M |
| Income tax expense (benefit) | $12.3M | $6.5M | -$12.7M |
| Net income | $19.1M | $17.0M | $28.5M |
| Basic (in dollars per share) | $1 | $1 | $1 |
| Diluted (in dollars per share) | $1 | $1 | $1 |
| Basic (in shares) | 22.9M shares | 23.9M shares | 22.9M shares |
| Diluted (in shares) | 23.3M shares | 24.1M shares | 23.2M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash | $83.4M | $94.4M | ||
| Accounts receivable, net | $43.9M | $44.9M | ||
| Net investment in leases | $15.8M | $14.5M | ||
| Inventories | $14.0M | $18.7M | ||
| Prepaid expenses and other current assets | $8.1M | $5.1M | ||
| Total current assets | $165.2M | $177.6M | ||
| Property and equipment, net | $5.1M | $5.6M | ||
| Right of use operating lease assets | $13.8M | $16.6M | ||
| Intangible assets, net | $39.2M | $42.8M | ||
| Goodwill | $31.1M | $31.1M | ||
| Deferred income taxes | $9.8M | $18.3M | ||
| Other non-current assets | $9.8M | $6.0M | ||
| Total non-current assets | $108.8M | $120.4M | ||
| Total assets | $273.9M | $297.9M | ||
| Accounts payable | $5.0M | $5.6M | ||
| Note payable | $3.0M | |||
| Accrued payroll and related taxes | $19.4M | $17.9M | ||
| Accrued expenses | $8.5M | $7.8M | ||
| Income taxes payable | $1.4M | $270.0K | ||
| Operating lease liabilities | $3.2M | $3.0M | ||
| Other current liabilities | $3.5M | $3.1M | ||
| Total current liabilities | $41.0M | $40.7M | ||
| Note payable, non-current | $23.2M | |||
| Accrued warranty reserve, non-current | $1.0M | $1.2M | $1.7M | |
| Income taxes payable, non-current | $275.0K | $239.0K | ||
| Operating lease liabilities, non-current | $12.8M | $16.0M | ||
| Total non-current liabilities | $14.1M | $40.6M | ||
| Total liabilities | $55.0M | $81.3M | ||
| Common stock, $0.001 par value, 300,000,000 shares authorized; 22,438,926 shares issued and outstanding as of December 31, 2025; 23,883,475 shares issued and outstanding as of December 31, 2024 | $22.0K | $24.0K | ||
| Additional paid-in capital | $163.9M | $180.7M | ||
| Retained earnings | $54.9M | $35.9M | ||
| Total stockholders' equity | $218.9M | $216.6M | $193.6M | $121.4M |
| Total liabilities and stockholders' equity | $273.9M | $297.9M | ||
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 50.0M shares | 50.0M shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized | 300.0M shares | 300.0M shares | ||
| Common stock, shares, issued | 22.4M shares | 23.9M shares | ||
| Common stock, shares, outstanding | 22.4M shares | 23.9M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash | $83.4M | $94.4M | ||
| Accounts receivable, net | $43.9M | $44.9M | ||
| Net investment in leases | $15.8M | $14.5M | ||
| Inventories | $14.0M | $18.7M | ||
| Prepaid expenses and other current assets | $8.1M | $5.1M | ||
| Total current assets | $165.2M | $177.6M | ||
| Property and equipment, net | $5.1M | $5.6M | ||
| Right of use operating lease assets | $13.8M | $16.6M | ||
| Intangible assets, net | $39.2M | $42.8M | ||
| Goodwill | $31.1M | $31.1M | ||
| Deferred income taxes | $9.8M | $18.3M | ||
| Other non-current assets | $9.8M | $6.0M | ||
| Total non-current assets | $108.8M | $120.4M | ||
| Total assets | $273.9M | $297.9M | ||
| Accounts payable | $5.0M | $5.6M | ||
| Note payable | $3.0M | |||
| Accrued payroll and related taxes | $19.4M | $17.9M | ||
| Accrued expenses | $8.5M | $7.8M | ||
| Income taxes payable | $1.4M | $270.0K | ||
| Operating lease liabilities | $3.2M | $3.0M | ||
| Other current liabilities | $3.5M | $3.1M | ||
| Total current liabilities | $41.0M | $40.7M | ||
| Note payable, non-current | $23.2M | |||
| Accrued warranty reserve, non-current | $1.0M | $1.2M | $1.7M | |
| Income taxes payable, non-current | $275.0K | $239.0K | ||
| Operating lease liabilities, non-current | $12.8M | $16.0M | ||
| Total non-current liabilities | $14.1M | $40.6M | ||
| Total liabilities | $55.0M | $81.3M | ||
| Common stock, $0.001 par value, 300,000,000 shares authorized; 22,438,926 shares issued and outstanding as of December 31, 2025; 23,883,475 shares issued and outstanding as of December 31, 2024 | $22.0K | $24.0K | ||
| Additional paid-in capital | $163.9M | $180.7M | ||
| Retained earnings | $54.9M | $35.9M | ||
| Total stockholders' equity | $218.9M | $216.6M | $193.6M | $121.4M |
| Total liabilities and stockholders' equity | $273.9M | $297.9M | ||
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 50.0M shares | 50.0M shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized | 300.0M shares | 300.0M shares | ||
| Common stock, shares, issued | 22.4M shares | 23.9M shares | ||
| Common stock, shares, outstanding | 22.4M shares | 23.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $19.1M | $17.0M | $28.5M |
| Depreciation and amortization | $6.6M | $6.8M | $6.5M |
| Deferred income taxes | $8.5M | $1.1M | -$19.4M |
| Stock-based compensation expense | $8.4M | $7.8M | $7.5M |
| Loss on disposal of property and equipment and intangibles | $78.0K | $308.0K | $3.0K |
| Change in fair value of earn-out liability | -$2.5M | ||
| Accounts receivable, net | $1.1M | -$1.8M | $11.7M |
| Net investment in leases | -$1.2M | -$345.0K | $1.9M |
| Inventories | $4.6M | $3.9M | $597.0K |
| Income taxes payable | $1.2M | -$1.4M | -$721.0K |
| Prepaid expenses and other assets | -$6.9M | -$3.9M | $72.0K |
| Right of use operating lease assets | -$142.0K | $187.0K | $71.0K |
| Accounts receivable, non-current | $10.9M | $12.1M | |
| Accounts payable | -$758.0K | -$1.1M | -$3.9M |
| Accrued payroll and related taxes | $1.5M | $1.1M | -$311.0K |
| Accrued expenses and other liabilities | $780.0K | $120.0K | -$6.5M |
| Net cash provided by operating activities | $42.8M | $40.7M | $35.9M |
| Purchases of property and equipment | -$2.4M | -$2.4M | -$2.3M |
| Proceeds from sale of property and equipment | $12.0K | ||
| Intangible assets expenditures | -$155.0K | -$117.0K | -$157.0K |
| Net cash used in investing activities | -$2.5M | -$2.5M | -$2.5M |
| Proceeds from issuance of note payable | $8.2M | ||
| Payments on earn-out | -$10.6M | ||
| Payments on note payable | -$26.2M | -$3.0M | -$3.0M |
| Payments on revolving line of credit | -$25.0M | ||
| Payments of deferred debt issuance costs | -$125.0K | ||
| Proceeds from exercise of common stock options | $222.0K | $24.0K | $14.0K |
| Proceeds from the issuance of common stock from the employee stock purchase plan | $1.4M | $1.7M | $1.5M |
| Payments for repurchases of common stock | -$26.6M | -$3.5M | |
| Proceeds from issuance of common stock at market | $34.6M | ||
| Net cash (used in) provided by financing activities | -$51.2M | -$4.8M | $5.7M |
| Net (decrease) increase in cash | -$10.9M | $33.3M | $39.1M |
| Cash paid for interest | $1.2M | $2.1M | $4.6M |
| Cash paid for taxes | $2.5M | $6.9M | $7.4M |
| Accrued excise tax on stock repurchases | $191.0K | ||
| Capital expenditures incurred but not yet paid | $78.0K | $76.0K | $528.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led TACTILE SYSTEMS TECHNOLOGY INC, and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
Chief operating officer
20202025
- Chief executive officerSheri Louise Dodd Aug 9, 2024 to now11
- Chief executive officerDaniel L. Reuvers Jun 15, 2020 to Feb 29, 202412
- Chief executive officerGerald R. Mattys Jul 27, 2016 to Apr 30, 202013
- PresidentDaniel L. Reuvers Jun 15, 2020 to Feb 29, 202412
- Chief financial officerElaine M. Birkemeyer Mar 22, 2023 to now14
- Chief financial officerBrent Moen Sep 5, 2018 to Mar 3, 202315
- Chief financial officerLynn Larson Blake Jul 27, 2016 to Aug 20, 201816
- Chief operating officerRobert J. Folkes Jul 27, 2016 to Mar 13, 202017
Board members and other officers (22)
- Senior VP, SalesSherri Lee Ferstler Aug 3, 2023 to Aug 14, 202418
- Senior VP, SalesEric Pauls May 7, 2021 to May 10, 202319
- Sr. VP Mktg & Clinical AffairsKristie Burns May 7, 2021 to now20
- Vice President, SalesBryan Rishe Jul 27, 2016 to Mar 9, 202121
- VP Payer Rltns & Govt AffrMaggie Thompson Jul 27, 2016 to May 14, 201922
- Vice President, ReimbursementMary E. Anderson Jul 27, 2016 to Jun 7, 201723
- Board memberAndrea Pearson Mar 11, 2026 to now24
- Board memberCarmen L. Diersen Jan 5, 2023 to now25
- Board memberBoyd Vindell Washington Oct 3, 2023 to now26
- Board memberDavid Brent Shafer Jan 12, 2022 to now27
- Board memberValerie L. Asbury Jan 12, 2022 to now28
- Board memberSheri Louise Dodd Jan 7, 2021 to now29
- Board memberDeepti Jain Jan 12, 2021 to May 11, 202230
- Board memberDaniel L. Reuvers Jun 15, 2020 to now12
- Board memberCheryl Pegus Aug 4, 2017 to May 6, 202031
- Board memberRaymond Huggenberger Sep 22, 2017 to now32
- Board memberGerald R. Mattys Jul 27, 2016 to Apr 30, 202013
- Board memberJordan Davis Jul 27, 2016 to Mar 1, 201833
- Board memberPeter H. Soderberg Jul 27, 2016 to May 19, 202134
- Board memberRichard Nigon Jul 27, 2016 to May 19, 202135
- Board memberWilliam W. Burke Jul 27, 2016 to now36
- Board memberZubeen Shroff Jul 27, 2016 to May 11, 201737
Timeline
Filings
282 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 39 major events, 110 insider forms, 42 large holders, 71 other. The latest 20:
- Aug 20, 2026144 EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 12, 20264 EDGAR
- Aug 12, 2026SCHEDULE 13G/A EDGAR
- Aug 10, 2026144 EDGAR
- Aug 10, 202610-Q EDGAR
- Aug 10, 20268-K EDGAR
- Jul 13, 20268-K EDGAR
- Jun 1, 2026SD EDGAR
- May 13, 20264 EDGAR
- May 11, 2026144 EDGAR
- May 8, 20264 EDGAR
- May 8, 20264 EDGAR
- May 8, 20264 EDGAR
- May 8, 20264 EDGAR
- May 8, 20264 EDGAR
- May 8, 20264 EDGAR
- May 8, 20264 EDGAR
- May 8, 20264 EDGAR
- May 7, 20268-K EDGAR
The 282 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 42 such filings since October 2021, the latest 10:
- Aug 14, 2026SCHEDULE 13G/A
- Aug 12, 2026SCHEDULE 13G/A
- Mar 27, 2026SCHEDULE 13G/A
- Feb 17, 2026SCHEDULE 13G/A
- Feb 12, 2026SCHEDULE 13G/A
- Feb 12, 2026SCHEDULE 13G/A
- Jan 21, 2026SCHEDULE 13G/A
- Oct 31, 2025SCHEDULE 13G/A
- Aug 7, 2025SCHEDULE 13G/A
- Jul 15, 2025SCHEDULE 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
3 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Nov 12, 2024 | Tina SmithDemocratic, Senate | Buy | $50,001 - $100,000 | +17.5% | Report |
| Nov 8, 2023 | Tina SmithDemocratic, Senate | Buy | $100,001 - $250,000 | +54.6% | Report |
| Jan 23, 2019 | Donna Shalala, House | Buy | $1,001 - $15,000 | −257.0% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARBrent Moen, Chief financial officer
- 16
- 17
- 18
- 19SEC EDGAREric Pauls, Senior VP, Sales
- 20
- 21SEC EDGARBryan Rishe, Vice President, Sales
- 22
- 23
- 24SEC EDGARAndrea Pearson, Board member
- 25SEC EDGARCarmen L. Diersen, Board member
- 26
- 27SEC EDGARDavid Brent Shafer, Board member
- 28SEC EDGARValerie L. Asbury, Board member
- 29SEC EDGARSheri Louise Dodd, Board member
- 30SEC EDGARDeepti Jain, Board member
- 31SEC EDGARCheryl Pegus, Board member
- 32SEC EDGARRaymond Huggenberger, Board member
- 33SEC EDGARJordan Davis, Board member
- 34SEC EDGARPeter H. Soderberg, Board member
- 35SEC EDGARRichard Nigon, Board member
- 36SEC EDGARWilliam W. Burke, Board member
- 37SEC EDGARZubeen Shroff, Board member
- 38